AN ADJUVANT FORMULATION CONTAINING TOLL-LIKE RECEPTOR 7 AGONIST STIMULATES PROTECTION AGAINST MORBIDITY AND MORTALITY DUE TO ANAPLASMA MARGINALE IN A HIGHLY ENDEMIC REGION OF WEST AFRICA.
Account has been disabled due to a violation of Terms of Service. Contact Moderators
Account has been disabled due to a violation of Terms of Service. Contact Moderators